Kenon KEN · NYSE
$60.84 +1.67% (+$1.00)
Summary
49 / 100 · Bulios Score
What speaks for it
- Revenue grew by 15% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 10 USD is left as net profit.
What to watch
- Earnings per share fell by 40% a year over the last 3 years.
- It pays out more in dividends than it earns: 167% of profit.
- It reports a profit, yet spends more cash than it brings in.
- It earns only 1.4 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against the industry (Independent Power Producers)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 15% a year. Earnings per share fell by 40% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 81 USD
- Sales and administration 8.8 USD
- Taxes and other -0.3 USD
- Net profit 10 USD
Net profit, industry median (Independent Power Producers) 6.0 USD
Out of every 100 USD of revenue, 10 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.44%
- Paid out of profit
- 167%
- Raised in a row
- 2 years
You receive $3.85 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- ISRAEL 77%
- UNITED STATES 23%
ISRAEL brings in 77% of revenue. UNITED STATES grew fastest, by 40% a year.
Segments in detail